Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Account Payables (2019 - 2025)

Historic Change in Account Payables for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$1.1 million.

  • Outset Medical's Change in Account Payables fell 15600.91% to -$1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.3 million, marking a year-over-year decrease of 6904.52%. This contributed to the annual value of -$3.3 million for FY2025, which is 6904.52% down from last year.
  • Per Outset Medical's latest filing, its Change in Account Payables stood at -$1.1 million for Q4 2025, which was down 15600.91% from $338000.0 recorded in Q3 2025.
  • Over the past 5 years, Outset Medical's Change in Account Payables peaked at $3.3 million during Q1 2022, and registered a low of -$4.1 million during Q2 2021.
  • For the 5-year period, Outset Medical's Change in Account Payables averaged around -$213800.0, with its median value being -$117000.0 (2023).
  • In the last 5 years, Outset Medical's Change in Account Payables surged by 53356.94% in 2023 and then tumbled by 81932.37% in 2024.
  • Outset Medical's Change in Account Payables (Quarter) stood at -$915000.0 in 2021, then grew by 22.84% to -$706000.0 in 2022, then soared by 533.57% to $3.1 million in 2023, then plummeted by 114.41% to -$441000.0 in 2024, then tumbled by 156.01% to -$1.1 million in 2025.
  • Its Change in Account Payables stands at -$1.1 million for Q4 2025, versus $338000.0 for Q3 2025 and $270000.0 for Q2 2025.